CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to evaluate the impact of screening for monoclonal gammopathy of undetermined significance (MGUS) on survival rates in individuals over 50. It seeks to integrate various biological markers to improve risk assessment and follow-up strategies for MGUS patients.
Monoclonal gammopathy of undetermined significance (MGUS) is a very common precursor condition to multiple myeloma (MM), and related diseases, and can be found in approximately 4-5% of individuals over the age of 50 years. MM is always preceded by MGUS.
Current risk stratification schemes, designed to predict those that will progress, are based on retrospective data and rely almost solely on serum protein markers.
While they can differentiate high and low-risk patients, they cannot predict outco…
HASKOLI ISLANDS
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
